Status:

COMPLETED

BALANCE Diet Implementation in Primary Health Care: a Cluster Randomized Type II Hybrid Implementation Study

Lead Sponsor:

Hospital do Coracao

Conditions:

Obesity

Hypertension

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

This is an implementation type II hybrid study with randomisation in cluster, whose objective is to compare two strategies of implementation of the Brazilian cardioprotective diet guidelines in primar...

Eligibility Criteria

Inclusion

  • Clusters Inclusion criteria: All Public Primary Care Units from both cities will be included. However, the Health services that encourage health professionals to use the Cardioprotective Food manual before randomization will be excluded.
  • Participants (patients) Inclusion criteria:
  • Individuals aged ≥20 years of either sex who have a previous medical diagnosis of at least one of the following conditions:
  • Type 2 diabetes mellitus;
  • Systemic arterial hypertension (Systolic blood pressure ≥140 mmHg or diastolic blood pressure greater than ≥90 mmHg or in drug treatment for hypertension);
  • Isolated hypercholesterolemia: isolated increase in LDL-c (LDL-c ≥ 160 mg/dL).
  • Isolated hypertriglyceridemia: isolated increase in triglycerides (TG ≥ 150 mg/dL or ≥ 175 mg/dL if the sample is obtained without fasting).
  • Obesity or overweight (body mass index ≥25.0 kg/m2).
  • Exclusion Criteria:
  • Prior cardiovascular event (acute myocardial infarction, stroke, peripheral arterial disease);
  • Psychiatric or neurocognitive condition that prevents understanding of guidelines (defined by the clinical judgment of the investigators);
  • Life expectancy less than 6 months (example: metastatic malignant neoplasm) to be defined by the investigator's judgment;
  • Pregnancy or lactation;
  • Liver failure with a previous history of encephalopathy or anasarca;
  • Chronic renal failure;
  • Organ transplantation;
  • Gastroplasty for less than a year;
  • Impossibility of oral feeding.
  • No access to internet or mobile phone.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 19 2023

    Estimated Enrollment :

    786 Patients enrolled

    Trial Details

    Trial ID

    NCT05310526

    Start Date

    November 1 2022

    End Date

    December 19 2023

    Last Update

    December 26 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Prefeitura Municipal de Foz do Iguaçu

    Foz do Iguaçu, Brazil